CDC investigating post-vaccine inflammation reports in the US
May 24, 2021Sales and Marketing
The US Centers for Disease Control (CDC) is looking in to a small number of reports that some young vaccine …
C. difficile infection Phase III trial meets primary endpoint
May 24, 2021Sales and Marketing
Ferring Pharmaceuticals and Rebiotix have presented Phase III results demonstrating superior efficacy of investigational RBX2660 in reducing recurrence of Clostridioides …
FDA grants accelerated approval for Janssen’s lung cancer drug
May 24, 2021Sales and Marketing
The FDA have granted accelerated approval of Rybrevant (amivantamab-vmjw) for the treatment of patients with metastatic non-small cell lung cancer …
Vaccines highly effective against Indian variant, study shows
May 24, 2021Sales and Marketing
A new Public Health England (PHE) study shows that two doses of either the Pfizer-BioNTech or the Oxford-AstraZeneca vaccine are …
BMS follow-up data sees long-term survival for melanoma patients
May 24, 2021Sales and Marketing BMS, skin cancer
Bristol Myers Squibb (BMS) has announced follow-up data from their Phase III CheckMate-067 clinical trial, which demonstrated that 49% of …
NICE rejects Janssen’s prostate cancer drug Erleada
May 21, 2021Medical Communications
NICE has published has published draft guidance rejecting Janssen’s Erleada (apalutamide) with androgen deprivation therapy (ADT) for treating prostate cancer. …
Australian PM calls for domestic mRNA vaccine production
May 21, 2021Medical Communications Australia, Moderna, Vaccine, mrna
Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …
Japan approves Moderna & AstraZeneca COVID-19 vaccines
May 21, 2021Medical Communications COVID-19, Japan, Vaccine
A Japanese government panel has approved Moderna and AstraZeneca’s COVID-19 vaccines for use in adults, bringing the total number of …
Dogs can detect COVID-19 with 97% accuracy, study finds
May 21, 2021Medical Communications
A French trial has found has found that dogs are able to detect COVID-19 with 97% accuracy in humans, which …
Pharmafile.com’s top 10 news stories of the week
May 21, 2021Medical Communications
Among our ten most-read stories this week: Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows, while a …
EU signs contract for 1.8bn more Pfizer vaccines
May 20, 2021The European Commission has signed a deal with Pfizer-BioNTech to purchase an additional 1.8 billion doses of its COVID-19 vaccine …
FDA clears IND application for GammaDelta’s cancer therapy treatment
May 20, 2021GammaDelta has received FDA clearance of its Investigational New Drug (IND) application for GDX012, a novel allogeneic variable delta 1 …
Vertex applies to expand indication of cystic fibrosis drug
May 20, 2021EMA, MHRA, cystic fibrosis
Vertex has announced that the EMA and MHRA have validated the post marketing applications for an expanded indication of Kaftiro …
New treatment available to patients with rare blood disorders
May 20, 2021Hundreds of people with rare blood disorders will have access to a new treatment following guidance from NICE today. The …
World’s first COVID-19 vaccine booster study launches in UK
May 20, 2021COVID-19, UK government, booster vaccine, clinical trial, vaccines
The UK government has announced that thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial, …
Pharmafile.com’s weekly COVID-19 news round-up
May 19, 2021Research and Development
The past week has seen lots of positive COVID-19 vaccine news; the Pfizer-BioNTech vaccine can be refrigerated much longer than …
‘Black fungus’ drug in short supply across India
May 19, 2021Research and Development
Amphotericin B, an anti-fungal drug used to treat the rare infection mucormycosis, or ‘black fungus’, is in short supply across …
UK medical cannabis study finds anxiety, pain, and sleep improvements
May 19, 2021Research and Development
The first ever UK medical cannabis study has found significant improvements in anxiety, pain, and sleep in patients following treatment …
Exscientia and BMS announce $1.2 billion collaboration
May 19, 2021Research and Development AI
Artificial intelligence (AI) pharmatech company, Exscientia, has announced a collaboration with Bristol Myers Squibb to accelerate the discovery of small …
BD unveils plan for €165 million Spanish manufacturing plant
May 19, 2021Research and Development EU, manufacturing
BD has announced plans to build a new €160 million manufacturing plant in Zaragoza, located in the Aragon region of …
Latest content
